The Industry Is Still Talking About Problems We Solved Years Ago
Attending SCRS 2026 earlier this year was both energizing and revealing. It was clear that many of the challenges dominating the conference - recruitment bottlenecks, site burden, operational inconsistency, unrealistic enrolment projections - are the same issues we’ve spent the last several years actively solving. What struck us most was how often people were surprised to learn just how much capability sits within hVIVO’s site and patient services function. Many still assume we are “just a challenge unit,” unaware that we operate as a fully capable early‑phase site with infrastructure, systems, and expertise that far exceed the industry norm.
The conversations at SCRS made one thing obvious: the industry is still wrestling with problems we’ve already moved beyond. And that gap between what we do and what people think we do is something we intend to close.
Most Sites Are Still Operating Like It’s 2010 — A Room, a Nurse, and a Hope
A recurring theme was the stark difference between traditional site models and what modern early‑phase research actually requires. Many sites still operate with minimal infrastructure: a single coordinator juggling recruitment, assessments, data entry, and patient management, all while trying to keep pace with increasingly complex protocols. That model may have worked a decade ago, but early‑phase studies have evolved. Protocols are more intricate. Eligibility criteria are more nuanced. Specialist populations are harder to reach. And sponsors expect evidence, not optimism.
Our model is fundamentally different. We operate as an integrated early‑phase ecosystem, not a standalone site. Our teams have access to project managers, data managers, scientific oversight, legal support, and operational specialists — all working together from the earliest stages of a study. That level of integration isn’t a luxury; it’s what modern early‑phase research demands.
Recruitment Has Become a Science — And We’ve Been Operating That Way for Years
One of the clearest takeaways from the conference was how far our recruitment capability has come — and how different it looks from the traditional site model. Over the past several years, we’ve built a recruitment function grounded in data, behavioural insight, and technology rather than assumptions about who will or won’t participate in early‑phase research. That shift has allowed us to understand our volunteer population with far greater precision and to design engagement strategies that reflect real‑world behaviour rather than industry folklore.
Instead of relying on broad demographic targeting, we developed a recruitment engine from the ground up — one that uses segmentation, analytics, and continuous learning to identify the right participants quickly and cost‑effectively. Our volunteer pool is refreshed year‑round, supported by systems that allow us to surface highly specific profiles in seconds. It’s a level of operational intelligence that many sites at SCRS were only beginning to explore.
Recruitment today isn’t about casting a wide net. It’s about understanding human behaviour, anticipating variability, and using data to guide every step of the process. We’ve been operating this way for years, and it shows in our performance.
Integration Is Our Real Differentiator
What truly sets us apart is not just recruitment sophistication or operational maturity — it’s the integration of everything under one roof. Most sites operate in silos: recruitment in one corner, data management in another, clinical operations somewhere else entirely. That fragmentation creates inefficiency and risk.
Our model is different. We work as a unified system. Recruitment informs feasibility. Clinical operations inform data capture. Data management informs protocol design. Scientific oversight ensures alignment across all functions. This integration reduces site burden, improves data quality, and creates a smoother experience for participants and sponsors alike.
In a world where early‑phase complexity is rising, integration isn’t an advantage — it’s a requirement.
SCRS also underscored how much of our operating model has been shaped by the realities of our work. High‑volume studies, complex eligibility criteria, and the need to recruit and manage challenging populations have pushed us to refine our processes, invest in technology, and build a more data‑driven approach to early‑phase delivery. What others are now beginning to explore out of aspiration, we developed out of necessity — and over time, those pressures have helped us create a model that is both efficient and resilient.
How Our Model Evolved — and Why It Matters Now
SCRS highlighted something we’ve long understood from our own experience: the pressures of high‑throughput studies, challenging populations, and compressed timelines have shaped the way we operate. Our recruitment model, our site processes, and our investment in technology didn’t emerge from theory — they were built in response to real‑world demands that required us to think differently about early‑phase delivery.
Over time, those pressures pushed us to develop a more data‑driven, science‑led, and operationally integrated approach than the traditional site model typically allows. What we saw at SCRS is that many organisations are now beginning to move in this direction, exploring the same kinds of tools, systems, and structures that we’ve relied on for years. It was a reminder that the challenges we’ve faced have ultimately become the foundation of our strength.
Our opportunity now is not to reinvent our model, but to articulate it more clearly. Sponsors, CROs, and partners increasingly need early‑phase environments that can manage complexity with precision, adapt quickly, and deliver predictable outcomes. That is the model we’ve built — one shaped by necessity, refined through experience, and supported by continuous investment in technology, segmentation, and operational intelligence.
The industry is evolving toward more integrated, insight‑driven early‑phase research. We’ve been operating this way for some time, and SCRS reinforced that our approach is aligned with where the field is heading.
Nature. 2022 Mar 29.
